PFM Health Sciences’s Dimension Therapeutics, Inc DMTX Stock Holding History

PFM Health Sciences’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-446,003	Closed	-$3.56M	–	123
2016 Q3	$3.56M	Sell	446,003 -220,067	-33%	-$1.59M	0.1%	83
2016 Q2	$4M	Sell	666,070 -59,099	-8%	-$450K	0.12%	74
2016 Q1	$5.52M	Sell	725,169 -90,190	-11%	-$710K	0.17%	77
2015 Q4	$8.38M	Buy	+815,359	New	+$10.3M	0.25%	58

Other funds holding DMTX

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

PFM Health Sciences's DMTX Position: Q4 2016 in Review

PFM Health Sciences sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2016, closing a stake of 446,003 shares — an estimated $3.56M sold.

PFM Health Sciences first reported a position in DMTX in Q4 2015 and held it in 4 quarters. The position peaked at $8.38M in Q4 2015. 55 funds tracked by Wall St. Rank hold DMTX as of Q4 2016.

PFM Health Sciences reported no remaining Dimension Therapeutics, Inc position as of Q4 2016 after selling out during the quarter.
PFM Health Sciences sold 446,003 Dimension Therapeutics, Inc shares in Q4 2016, an estimated $3.56M.
PFM Health Sciences first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 4 quarters.
PFM Health Sciences's Dimension Therapeutics, Inc position peaked at $8.38M in Q4 2015.
55 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2016.

Based on PFM Health Sciences's 13F filing for Q4 2016, filed 14 Feb 2017.